Follow-up of Phase I/II study of CaspaCIDe T cells (BPX-501) from an HLA-partially matched family donor after negative selection of TCR αβ+T cells in pediatric patients affected by hematological disorders
2022-06-29
عنوان الدراسة
Follow-up of Phase I/II study of CaspaCIDe T cells (BPX-501) from an HLA-partially matched family donor after negative selection of TCR αβ+T cells in pediatric patients affected by hematological disorders
داعم الدراسة
Bellicum Pharmaceuticals
دواء الدراسة
Rimiducid
رقم بروتوكول الدراسة
CT17-008-R
حالة الدراسة
Ongoing
موقع الدراسة
NGHA-R
مرحلة الدراسة
1/2
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。